Giuseppe Celiberti is the new CEO & General Manager of IBSA Italy, the largest subsidiary of the Swiss Group and a leading player in the Italian pharmaceutical industry. The appointment marks a new phase for the company, which is consolidating its growth in the Italian market, strengthening its structure and presence in the main therapeutic areas of reference.
Celiberti, with a solid scientific background and consolidated managerial experience in the pharmaceutical and healthcare sector, will lead IBSA Italy in achieving its objectives in line with the Group's overall research, development, and growth process.
“Taking the helm at IBSA Italy is an important responsibility and a source of great pride for me” said Giuseppe Celiberti, CEO of IBSA Italy. "Our ability to put people first is not just a value, it is the driving force that allows us to combine scientific research, industrial production, and innovation as the pillars of our daily commitment. Together with the entire team, we will continue to work to consolidate growth in Italy and accelerate the Group's international development, promoting medicines in the best possible form, capable of effectively responding to the needs of all our patients and improving their compliance."
Read the press release.
